Smruthi Organics [SMRUTHIORG] vs Aarti Drugs [AARTIDRUGS] Detailed Stock Comparison

Smruthi Organics

BSE
Loading...

Aarti Drugs

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Smruthi Organics wins in 8 metrics, Aarti Drugs wins in 11 metrics, with 0 ties. Aarti Drugs appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricSmruthi OrganicsAarti DrugsBetter
P/E Ratio (TTM)43.1923.66Aarti Drugs
Price-to-Book Ratio2.043.26Smruthi Organics
Debt-to-Equity Ratio23.6544.92Smruthi Organics
PEG Ratio2.330.37Aarti Drugs
EV/EBITDA13.7917.07Smruthi Organics
Profit Margin (TTM)2.88%7.80%Aarti Drugs
Operating Margin (TTM)-6.21%10.11%Aarti Drugs
EBITDA Margin (TTM)N/A10.11%N/A
Return on Equity4.97%12.28%Aarti Drugs
Return on Assets (TTM)3.19%6.53%Aarti Drugs
Free Cash Flow (TTM)$-15.39M$674.22MAarti Drugs
Dividend Yield2.45%0.22%Smruthi Organics
1-Year Return-5.31%-4.79%Aarti Drugs
Price-to-Sales Ratio (TTM)1.241.84Smruthi Organics
Enterprise Value$1.62B$50.47BAarti Drugs
EV/Revenue Ratio1.372.08Smruthi Organics
Gross Profit Margin (TTM)53.11%36.77%Smruthi Organics
Revenue per Share (TTM)$103$265Aarti Drugs
Earnings per Share (Diluted)$2.96$20.63Aarti Drugs
Beta (Stock Volatility)-0.100.12Smruthi Organics
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Smruthi Organics vs Aarti Drugs Stock Performance Analysis

Loading Price Chart...

Smruthi Organics
Aarti Drugs
Smruthi Organics Stock Overview | Aarti Drugs Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Smruthi Organics3.23%2.50%16.65%3.39%10.32%6.68%
Aarti Drugs0.73%4.61%0.24%1.59%41.06%7.93%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Smruthi Organics-5.31%-37.90%41.21%-23.44%-17.38%85.03%
Aarti Drugs-4.79%-0.89%-50.06%219.30%2,690.01%2,872.19%

News Based Sentiment: Smruthi Organics vs Aarti Drugs

Smruthi Organics

News based Sentiment: NEGATIVE

Smruthi Organics experienced a significant downturn in September, reporting a loss after three profitable quarters and a substantial revenue decline. This, coupled with regulatory scrutiny and conflicting analyst opinions, creates a concerning picture for investors, making it a pivotal month for the company's trajectory.

View Smruthi Organics News Sentiment Analysis

Aarti Drugs

News based Sentiment: POSITIVE

Aarti Drugs reported substantial profit growth in both Q1FY26 and FY2025, coupled with increased institutional interest from Mutual Funds. While shareholding changes and recent price volatility exist, the overall narrative points towards a strengthening investment case.

View Aarti Drugs News Sentiment Analysis

Performance & Financial Health Analysis: Smruthi Organics vs Aarti Drugs

MetricSMRUTHIORGAARTIDRUGS
Market Information
Market Cap i₹1.56B₹44.55B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i4,127201,942
90 Day Avg. Volume i13,180187,563
Last Close₹131.00₹491.60
52 Week Range₹103.00 - ₹169.00₹312.00 - ₹564.05
% from 52W High-22.49%-12.84%
All-Time High₹419.35 (Jul 12, 2021)₹1,026.95 (Oct 05, 2020)
% from All-Time High-68.76%-52.13%
Growth Metrics
Quarterly Revenue Growth-0.30%0.06%
Quarterly Earnings Growth-0.30%0.62%
Financial Health
Profit Margin (TTM) i0.03%0.08%
Operating Margin (TTM) i-0.06%0.10%
Return on Equity (TTM) i0.05%0.12%
Debt to Equity (MRQ) i23.6544.92
Cash & Liquidity
Book Value per Share (MRQ)₹62.58₹149.84
Cash per Share (MRQ)₹0.38₹2.48
Operating Cash Flow (TTM) i₹195.06M₹2.83B
Levered Free Cash Flow (TTM) i₹35.63M₹1.68B
Dividends
Last 12-Month Dividend Yield i2.45%0.22%
Last 12-Month Dividend i₹3.00₹1.00

Valuation & Enterprise Metrics Analysis: Smruthi Organics vs Aarti Drugs

MetricSMRUTHIORGAARTIDRUGS
Price Ratios
P/E Ratio (TTM) i43.1923.66
Forward P/E iN/A15.02
PEG Ratio i2.330.37
Price to Sales (TTM) i1.241.84
Price to Book (MRQ) i2.043.26
Market Capitalization
Market Capitalization i₹1.56B₹44.55B
Enterprise Value i₹1.62B₹50.47B
Enterprise Value Metrics
Enterprise to Revenue i1.372.08
Enterprise to EBITDA i13.7917.07
Risk & Other Metrics
Beta i-0.100.12
Book Value per Share (MRQ) i₹62.58₹149.84

Financial Statements Comparison: Smruthi Organics vs Aarti Drugs

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)SMRUTHIORGAARTIDRUGS
Revenue/Sales i₹189.92M₹5.91B
Cost of Goods Sold i₹89.06M₹3.73B
Gross Profit i₹100.86M₹2.17B
Research & Development iN/AN/A
Operating Income (EBIT) i₹-11.79M₹593.60M
EBITDA i₹3.17M₹743.90M
Pre-Tax Income i₹-15.53M₹511.10M
Income Tax i₹-4.58M₹-28.60M
Net Income (Profit) i₹-10.95M₹539.70M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)SMRUTHIORGAARTIDRUGS
Cash & Equivalents i₹4.36M₹45.77M
Total Current Assets i₹633.33M₹13.38B
Total Current Liabilities i₹310.76M₹8.37B
Long-Term Debt i₹81.62M₹2.86B
Total Shareholders Equity i₹716.29M₹13.69B
Retained Earnings i₹583.25M₹12.40B
Property, Plant & Equipment i₹110.00M₹27.03M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)SMRUTHIORGAARTIDRUGS
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSMRUTHIORGAARTIDRUGS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i4,127201,942
Average Daily Volume (90 Day) i13,180187,563
Shares Outstanding i11.45M91.27M
Float Shares i3.78M39.04M
% Held by Insiders i0.67%0.60%
% Held by Institutions i0.00%0.11%

Dividend Analysis & Yield Comparison: Smruthi Organics vs Aarti Drugs

MetricSMRUTHIORGAARTIDRUGS
Last 12-Month Dividend i₹3.00₹1.00
Last 12-Month Dividend Yield i2.45%0.22%
3-Year Avg Annual Dividend i₹3.33₹1.00
3-Year Avg Dividend Yield i1.43%0.23%
3-Year Total Dividends i₹10.00₹3.00
Ex-Dividend DateJun 13, 2025Feb 04, 2025